INOV Investor Presentation
Differentiated
Capabilities for
Life Sciences
Life Sciences
Strategy
Clinical Analytics
Health Plan
Operations
Subject Matter Expertise
Outcomes
Research
Clinical Decision
Support
Healthcare
Economics
Reimbursement
& Revenue Cycle
Clinical
Interoperability
Pharmacy
Market Access
Predictive
Analytics
Technical
Architecture
Large-Scale Real-World MORE² RegistryⓇ Data Registry
Leveraging Inovalon's massive data
assets, deep subject matter expertise,
and the advanced technologies of the
Inovalon ONE® Platform, life sciences
clients benefit from not only data
empowered advisory services able to
inform strategy and commercialization,
but also inform the configuration of
Inovalon ONE® Platform configurations
that support outcomes-based contracting,
improved compliance and persistence,
and advanced business models.
319 Million
Patients
Massive
INOV Investor Presentation (8.20) v 1.0.3
56 Billion
Clinical Events
+
1,005,000
Physicians
559,000
Clinical Facilities
010100
10101001
0101000
0101000
Advanced Technologies Platform
1010100
0010001
0011
001
a
MC
Data Assets
Advanced
Analytics
Intervention
Toolsets
Data
Visualization
49View entire presentation